hemispherx biopharma inc
(HEB:Consolidated issues listed on NYSE MKT LLC)
Robert Dickey IV
Former Senior Vice President and Chairman of Disclosure Controls Committee, Hemispherx Biopharma, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 5 different industries.|
Mr. Robert Dickey, IV, also known as Rob, serves as Managing Director of DSS Partners LLC. Mr. Dickey served as the Chief Financial Officer of Neostem, Inc. since August 19, 2013. Mr. Dickey served as a Senior Vice President of Hemispherx Biopharma, Inc. from June 2009 to August 16, 2013. He served as Vice President of Neostem, Inc. Mr. Dickey served as the Chief Financial Officer and Senior Vice President of StemCyte, Inc. since July 2007. He served as the Chief Financial ...
One Penn CenterPhone: 215-988-0080
Philadelphia, Pennsylvania 19103
Board Members Memberships*
Former Senior Director
University of Pennsylvania - The Wharton School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Frank Mathias||Chief Executive Officer and Member of Executive Board|
|Brenton L. Saunders J.D.||Chief Executive Officer, President and Director|
|Robert L. Parkinson Jr.||Chairman, Chief Executive Officer and President|
Baxter International Inc.
|Pascal Soriot||Chief Executive Officer, Executive Director and Member of Disclosure Committee|
|Edward M. Kaye M.D., Ph.D.||Interim Chief Executive Officer, Chief Medical Officer and Senior Vice President|
Sarepta Therapeutics, Inc.
|$399.0K||Compensation as of Fiscal Year 2014.|